Cattle & Porcine/Swine Reproductive Diseases Market

The report "Cattle & Porcine/Swine Reproductive Diseases Market by Product (Diagnostics (ELISA, PCR, Rapid Antigen Testing), Pharmaceuticals (Vaccines), Supplements, Animal Type, Disease (BVD, PRRS, Leptospirosis, Brucellosis), End User - Global Forecast to 2029", is projected to reach USD 975.8 million by 2029 from USD 758.2 million in 2024 at a CAGR of 5.2%.

Browse 335 market data Tables and 66 Figures spread through 333 Pages and in-depth TOC on "Cattle & Porcine/Swine Reproductive Diseases Market by Product (Diagnostics (ELISA, PCR, Rapid Antigen Testing), Pharmaceuticals (Vaccines), Supplements, Animal Type, Disease (BVD, PRRS, Leptospirosis, Brucellosis), End User - Global Forecast to 2029"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/cattle-porcine-swine-reproductive-diseases-market-241160711.html

A few factors are contributing to the growth of the cattle & porcine/swine reproductive diseases market. Rising demand for meat and dairy products in the consumer market is making more focus on keeping animals healthy, thus increasing the demand for solution products related to their reproductive health. Growing problems related to reproductive health in cattle and pigs increase the demand for treatments and preventative measures. An increase in veterinary practitioners across the developed areas is also improving access to care, which is further supporting market expansion. In addition, better government and animal welfare activities are promoting more healthy animal practices, which subsequently increases veterinary product adoption. All these factors are therefore contributing to increased growth in the market as there will be a greater need for efficient reproductive health management in livestock.

“Based on product, the pharmaceuticals segment has accounted for the largest market share in the Cattle & porcine/swine reproductive diseases market.”

In 2023, the pharma market segment dominated the global Cattle & porcine/swine reproductive diseases market. Such high growth rates could be attributed to advancements in vaccine manufacturing, such as more effective formulations and sustainable production practices that have driven growth within this segment, besides increasing incidences of reproductive diseases within farm animals that create a high demand for these pharmaceutical products. Enhanced diagnostic means also enhance the utility of vaccines and antibiotics due to more timely and proper diagnosis of diseases. Continued innovation in the segment that goes towards more improved efficacy of vaccines as well as antibiotics has consolidated the position of Pharmaceuticals at the top of the market hierarchy.

“Based on Disease type, Porcine Reproductive and Respiratory Syndrome (PRRS) segment accounted the second largest share in the Cattle & porcine/swine reproductive diseases market.”

This segment of Porcine Reproductive and Respiratory Syndrome accounts for the second largest share in the Cattle & porcine/swine reproductive diseases market. It is fueled by its high incidence and the high economic cost it incurs within the pig industry. PRRS causes severe reproductive failures in breeding animals and respiratory complications in young pigs, which lead to severe losses in production. The fast mutation rate of the virus does not allow keeping the situation under control, and thus, the demand for more potent vaccines and treatments has been rising. Other factors that lead to its intensification are pig farming, world trade of pigs and pork products, and developing more developed diagnostic tools.

“Based of animal type, Porcine segment has witnesses the fastest CAGR in the Cattle & porcine/swine reproductive diseases market.”

Porcine segment had the highest CAGR in the Cattle & porcine/swine reproductive diseases market. Growth of Porcine segment in this Market is driven by multiple factors. Primarily, the global rise in pork consumption and the intensification of pig farming practices elevate the risk of disease transmission, which, in turn, emphasizes the need for effective disease control measures. The significant economic losses associated with swine diseases, such as PRRS, bring home the extensive investments in the control and prevention of such diseases. Moreover, new vaccine and treatment technologies for porcine diseases develop ways of controlling and preventing such outbreaks. As the pork production continues to rapidly expand, constant attention must be given to controlling the reproductive diseases in pigs to increase further demands in the market.

“On the basis of end users, cattle and porcine farms segment in the Cattle & porcine/swine reproductive diseases market has accounted the largest market share.”

Among the end-user type, cattle and porcine farms led in accounting for the largest market share in the cattle & porcine/swine reproductive diseases market in 2023. Growth progresses through various factors. First, with an increase in farming operations and increasing herd sizes, the susceptibility of such outbreaks increases manifold, which further results in the need for more strenuous management solutions for the diseases. Advanced farm technology and management practices have enhanced the sophisticated monitoring and control of diseases, and therefore, farms need to invest in modern diagnostic and treatment strategies. Then, there are the pressure on farms to become productive and profitable, forcing them to use integrative methods of disease prevention as a way of avoiding losses and taking good care of their livestock. This combined focus on efficiency and disease control is the biggest reason why the market segment is being driven at such breakneck pace.

“Based on Region, APAC is expected to witness the fastest CAGR in the under health during the forecast period.”

Some key drivers for growth in the region are presented herein. The rapid growth in the APAC region in terms of urbanization and increase in population has put massive pressure on meat demand, contributing to increased livestock farming. This increased pressure has increased awareness and investment in animal health, particularly reproductive disease management. Government initiatives in countries like China and India through veterinary healthcare improvement measures and livestock productivity enhancement have also played a role. In addition, several climate conditions in the region can elevate the cases of reproductive diseases, making it more prudent to have a high level of disease control in place. Second, the development of agribusiness and introduction of high-technology farming techniques increased concentration in preventing diseases thereby enhancing market growth.

Key Market Players:

Prominent players in the Cattle & porcine/swine reproductive diseases market include Zoetis Inc. (US), Merck & Co., Inc. (US), Boehringer Ingelheim International GmBH (Germany), Virbac (France), Elanco Animal Health Incorporated (US), Vetoquinol S.A. (France), Ceva Santé Animale (France), Idexx Laboratories (US), Thermo Fisher Scientific Inc. (US), Biochek Smart Veterinary Diagnostics (Netherlands), Ring Biotechnology Co Ltd. (China), Sequent Scientific Limited (India), Hipra (Spain), Qiagen N.V. (Germany), Innovative Diagnostics (France), Colorado Serum Company (US), Indian Immunologicals Ltd (US), Refit Animal Care (India), Calier (US), Megacor Diagnostik GmBH (Austria), Vetanco (Brazil), Biogenesis Bago (Argentina), Advacare Pharma (US), Bio-X Diagnostics S.A. (Belgium), Pax Healthcare (India).

Don’t miss out on business opportunities in Cattle & Porcine/Swine Reproductive Diseases Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]